Full Text
Innovation May Drive Streamlined Access to New Biopharmaceuticals Across Some Emea Markets

Abstract

Authors

R.B. Gardiner R. White

Back to Volume 17, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×